Dolby Laboratories, Inc. (FRA:FUO)
Germany · Delayed Price · Currency is EUR 52.00
+1.00 (1.96%)
At close: Jan 30, 2026
Dolby Laboratories Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 26, 2025 | Sep '25 Sep 26, 2025 | Sep '24 Sep 27, 2024 | Sep '23 Sep 29, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 24, 2021 |
| 1,339 | 1,349 | 1,274 | 1,300 | 1,254 | 1,281 | |
Revenue Growth (YoY) | 1.80% | 5.92% | -2.00% | 3.67% | -2.14% | 10.28% |
Cost of Revenue | 162.57 | 160.13 | 140.5 | 152.57 | 141.36 | 130.03 |
Gross Profit | 1,176 | 1,189 | 1,133 | 1,147 | 1,112 | 1,151 |
Selling, General & Admin | 644.54 | 647.24 | 604.85 | 612.84 | 634.03 | 556.83 |
Research & Development | 264.23 | 261.79 | 263.66 | 271.52 | 261.17 | 253.64 |
Operating Expenses | 908.78 | 909.03 | 868.52 | 884.36 | 895.21 | 810.47 |
Operating Income | 267.5 | 279.97 | 264.71 | 262.81 | 217.23 | 340.76 |
Interest & Investment Income | 16.85 | 15.38 | 34.08 | 28.09 | 6.17 | 3.01 |
Earnings From Equity Investments | 25.1 | 24.1 | 14.2 | 5.1 | 5 | 4.7 |
Currency Exchange Gain (Loss) | 1.25 | 1.25 | 1.8 | 0.54 | -1.28 | -0.75 |
Other Non Operating Income (Expenses) | -1.54 | -2.34 | 3.88 | 0.58 | -1.22 | 3.16 |
EBT Excluding Unusual Items | 309.16 | 318.35 | 318.67 | 297.11 | 225.9 | 350.88 |
Merger & Restructuring Charges | -20.26 | -15.01 | -6.38 | -47.06 | -10.62 | -10.24 |
Gain (Loss) on Sale of Investments | 0.14 | 0.14 | 0.19 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 13.87 |
Pretax Income | 289.04 | 303.49 | 312.48 | 250.05 | 215.28 | 354.51 |
Income Tax Expense | 46.93 | 46.99 | 48.16 | 48.41 | 31.38 | 36.69 |
Earnings From Continuing Operations | 242.1 | 256.49 | 264.32 | 201.64 | 183.9 | 317.82 |
Minority Interest in Earnings | -1.58 | -1.47 | -2.49 | -0.99 | 0.19 | -7.6 |
Net Income | 240.52 | 255.02 | 261.83 | 200.66 | 184.09 | 310.23 |
Net Income to Common | 240.52 | 255.02 | 261.83 | 200.66 | 184.09 | 310.23 |
Net Income Growth | -8.43% | -2.60% | 30.48% | 9.00% | -40.66% | 34.09% |
Shares Outstanding (Basic) | 96 | 96 | 96 | 96 | 100 | 101 |
Shares Outstanding (Diluted) | 97 | 97 | 97 | 98 | 102 | 105 |
Shares Change (YoY) | 0.07% | 0.16% | -0.42% | -4.17% | -2.52% | 1.63% |
EPS (Basic) | 2.51 | 2.66 | 2.74 | 2.10 | 1.84 | 3.07 |
EPS (Diluted) | 2.47 | 2.62 | 2.69 | 2.05 | 1.81 | 2.97 |
EPS Growth | -8.48% | -2.60% | 31.22% | 13.26% | -39.06% | 32.00% |
Free Cash Flow | 386.02 | 435.85 | 297.25 | 336.74 | 270.65 | 393.3 |
Free Cash Flow Per Share | 3.97 | 4.47 | 3.05 | 3.45 | 2.65 | 3.76 |
Dividend Per Share | 1.380 | 1.350 | 1.230 | 1.110 | 1.020 | 0.910 |
Dividend Growth | 9.52% | 9.76% | 10.81% | 8.82% | 12.09% | 3.41% |
Gross Margin | 87.86% | 88.13% | 88.97% | 88.26% | 88.72% | 89.85% |
Operating Margin | 19.98% | 20.75% | 20.78% | 20.22% | 17.33% | 26.60% |
Profit Margin | 17.96% | 18.90% | 20.56% | 15.44% | 14.68% | 24.21% |
Free Cash Flow Margin | 28.83% | 32.31% | 23.34% | 25.91% | 21.59% | 30.70% |
EBITDA | 357.11 | 367.79 | 340.27 | 345.37 | 305.69 | 436.62 |
EBITDA Margin | 26.67% | 27.26% | 26.71% | 26.57% | 24.38% | 34.08% |
D&A For EBITDA | 89.61 | 87.83 | 75.56 | 82.56 | 88.46 | 95.86 |
EBIT | 267.5 | 279.97 | 264.71 | 262.81 | 217.23 | 340.76 |
EBIT Margin | 19.98% | 20.75% | 20.78% | 20.22% | 17.33% | 26.60% |
Effective Tax Rate | 16.24% | 15.48% | 15.41% | 19.36% | 14.58% | 10.35% |
Revenue as Reported | 1,339 | 1,349 | 1,274 | 1,300 | 1,254 | 1,281 |
Advertising Expenses | - | 51.02 | 57.34 | 59.82 | 51.42 | 52.25 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.